Comparative effectiveness and safety of prasugrel versus ticagrelor following percutaneous coronary intervention: An observational study.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 515, doi. 10.1002/phar.2530
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2021 AND VI 41 AND IP 6
Results: 8
1
2
Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 537, doi. 10.1002/phar.2528
- By:
- Publication type:
- Article
3
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 526, doi. 10.1002/phar.2527
- By:
- Publication type:
- Article
4
Achievement of goal anti‐Xa activity with weight‐based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 508, doi. 10.1002/phar.2526
- By:
- Publication type:
- Article
5
Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 501, doi. 10.1002/phar.2525
- By:
- Publication type:
- Article
6
Use of Remdesivir in Myasthenia gravis and COVID‐19.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 546, doi. 10.1002/phar.2524
- By:
- Publication type:
- Article
7
Accuracy of a single‐lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 494, doi. 10.1002/phar.2521
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 491, doi. 10.1002/phar.2288
- Publication type:
- Article